Ophthalmology Times Europe parent company MJH Life Sciences® acquires eye care conference EnVision Summit

News
Article

The Eye Care Network adds a longstanding, CME-certified conference to its live event programming

An aerial view of San Juan, Puerto Rico. Image credit: ©Jacob – stock.adobe.com

The upcoming EnVision Summit is scheduled for 14-17 February, 2025, at the Caribe Hilton, San Juan, Puerto Rico. Image credit: ©Jacob – stock.adobe.com

Ophthalmology Times Europe is proud to report that MJH Life Sciences® has announced its acquisition of the EnVision Summit, a premier certified continuing medical education (CME) ophthalmology conference. The EnVision Summit, held annually in Puerto Rico, combines an innovative CME-certified education programme with a first-class family experience.

The summit will be hosted as a CME-certified conference within the Physicians’ Education Resource® legacy portfolio, supported by the eye care network brands Ophthalmology Times and Optometry Times. MJH Life Sciences noted in a press release that the acquisition aligns with its long-term growth strategy supported by a strategic partnership with BDT & MSD Partners.

The holistic approach to the summit includes age-appropriate activities for participants' family members, including children. In 2024, the EnVision Summit debuted an optometry track concurrent with the existing ophthalmology sessions.

Bonnie An Henderson, MD, the EnVision Summit director and cofounder, expressed enthusiasm about the future of the summit under MJH Life Sciences’ leadership. Dr Henderson President and CEO of global nonprofit HelpMeSee, as well as a past president of the American Society of Cataract and Refractive Surgery.

“I am thrilled about the possibilities that this acquisition brings for the EnVision Summit,” Dr Henderson said. “With the resources and expertise of MJH Life Sciences, we will be able to elevate our educational offerings to new heights, ensuring that eye care professionals worldwide have access to the most current and comprehensive information in multiple channels to better serve their patients. I look forward to continuing as the Programme Director to maintain the excellence of the content and faculty.”

Mike Hennessy Jr., president and CEO of MJH Life Sciences, commented on the news, describing it as a continuation of MJH Life Sciences’ mission. “As we continue to expand our commitment to education in the eye care space, the acquisition of EnVision Summit allows us to build on the strong foundation we’ve established with our leading brands,” he said. “The summit and its hundreds of loyal attendees will benefit not only from our expertise in providing engaging educational experiences on cutting-edge topics, but also from new and expanded opportunities to help them address the rapidly evolving ophthalmic landscape.”

The upcoming EnVision Summit is scheduled for 14-17 February, 2025, at the Caribe Hilton, San Juan, Puerto Rico.

To learn more and to register for the event, please visit www.envisionsummit.org.

Reference

1. MJH Life Sciences® acquires EnVision Summit, expands leadership in eye care education. MJH Life Sciences. Press release. Accessed 9 October, 2024.
Recent Videos
David Yorston, FRCS, FRCOphth, discusses his EURETINA keynote lecture
Hoda Shamsnajafabadi, MSc, PhD, presents at the 2024 EURETINA meeting
Timothy L Jackson PhD, MB ChB, FRCOphth, speaks about a combination therapy for VEGF-A/C/D inhibition with sozinibercept and ranibizumab
Carl Awh, MD, FASRS, speaks about the American Society of Retina Specialists (ASRS) at EURETINA
Stefano Mercuri, MD, first author of the winning eposter “Genotype-phenotype correlations in a cohort of genetically determined Retinitis Pigmentosa (RP) Italian patients with Rho gene mutations”
Bahram Bodaghi, MD, PHD, FEBO at the 2024 EURETINA meeting
Enrico Borrelli, MD, FEBO, speaks at EURETINA
Aleksandra Rachitskaya, MD, FASRS, speaks about the Vit-Buckle Society at the 2024 EURETINA Congress.
© 2024 MJH Life Sciences

All rights reserved.